Cingulate Inc. Common Stock (CING) News

Latest headlines that mention CING, newest first · each headline opens the original publisher

CING quote

Last price: $4.66
Day change: +0.00%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

CING headlines

latest coverage

Not much coverage yet. CING has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha 2mo ago

Cingulate reports Q2 results

Earnings T2CING

Investing.com 2mo ago

Cingulate reports Q2 loss, plans FDA resubmission for ADHD drug

General T3CING

Investing.com 2mo ago

Cingulate publishes phase 3 ADHD drug trial results in journal

General T3CING

Seeking Alpha 3mo ago

Cingulate added to Russell 3000E Index

General T2CING

Investing.com 4mo ago

Form 8K Cingulate Inc For: 16 June

General T3CING

Investing.com 4mo ago

Cingulate director Hargroves buys $490,271 of common stock

General T3CING

Investing.com 4mo ago

Cingulate stock reaffirmed at Buy by H.C. Wainwright ahead of FDA decision

General T3CING

Seeking Alpha 5mo ago

Cingulate reports Q1 results

Earnings T2CING

Investing.com 5mo ago

Cingulate reports Q1 loss, raises cash runway into 2027

General T3CING

Investing.com 5mo ago

Form 8K Cingulate Inc For: 14 May

General T3CING

CING news alerts

Get an alert by email or push when a new headline mentions CING.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.